Memorial Park Psychiatry

What Memorial Park Psychiatry does

Memorial Park Psychiatry is a physician-led psychiatric practice headquartered at 550 Westcott St, Suite 520, Houston, Texas, providing diagnostic evaluations and treatment for children, adolescents, and adults with mental health conditions including depression, anxiety, ADHD, bipolar disorder, OCD, PTSD, schizophrenia, eating disorders, and substance use disorders. The practice operates under the Beacon Behavioral Partners nationwide network of physician-led psychiatric practices and is staffed by two board-certified psychiatrists (Matthew Brams, M.D. and Alice Mao, M.D.) with academic appointments at Baylor College of Medicine, supported by a team of psychiatric mental health nurse practitioners and clinical/administrative coordinators.

The practice's clinical service stack combines standard psychiatric care (evaluations, medication management) with advanced modalities: NeuroStar Transcranial Magnetic Stimulation (TMS) for treatment-resistant depression, anxiety, and OCD; Spravato (esketamine) nasal spray therapy for treatment-resistant depression; Suboxone medication-assisted treatment for opioid dependence; T.O.V.A. computerized ADHD testing; and pharmacogenomic genetic testing to guide psychiatric medication selection. Services are delivered in person at the Houston office and through telepsychiatry, with board-certified clinicians handling both initial evaluations and longitudinal medication management.

The business model is fee-for-service psychiatric care reimbursed through nine major insurance networks (Aetna, Blue Cross Blue Shield, Cigna, Compsych, Humana, Magellan, MHN, United Behavioral Health, Value Options), supplemented by self-pay and higher-acuity procedural revenue from TMS, Spravato, and Suboxone. Demand is generated via physician referrals (with administrative staff handling patient outreach), insurance directory visibility, a content/blog presence on treatments such as Spravato, and social media on Instagram and Facebook. Clinical research activity is conducted through Empathx MPP, with Dr. Brams serving as Principal Investigator across trials spanning multiple therapeutic areas.

Name

Memorial Park Psychiatry

Legal name

Memorial Park Psychiatry

Website

https://memorialparkpsychiatry.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

Memorial Park Psychiatry is a physician-led Houston psychiatric practice providing diagnostic evaluations, medication management, and advanced treatments (TMS, Spravato, Suboxone, genetic testing) to children, adolescents, and adults, operating under the Beacon Behavioral Partners network.

Ownership category

akta.pro rank

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Psychiatric Evaluation and Treatment Services: The practice generates revenue through psychiatric evaluations, medication management, and ongoing treatment appointments for mental health conditions including depression, anxiety, ADHD, bipolar disorder, and other psychiatric disorders.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Memorial Park Psychiatry is a physician-led psychiatric practice in Houston providing diagnostic evaluations, medication management, and advanced treatment options such as TMS Therapy, Spravato (esketamine) treatment, and genetic testing for psychiatric medication response. The practice serves children, adolescents, and adults with mental health conditions, with services delivered in-person and via telemedicine.

Product overview

Memorial Park Psychiatry is a physician-led psychiatric practice offering a coordinated suite of clinical services for children, adolescents, and adults. Its core clinical offerings include TMS Therapy (Transcranial Magnetic Stimulation), Spravato (esketamine) Treatment, and Suboxone Medication-Assisted Treatment, supplemented by foundational services in Medication Management, Psychiatric Evaluations, TOVA ADHD Testing, and Genetic Testing for personalized medication selection. The practice also provides specialized care for Chemical Dependency, Eating Disorders, ADHD/ADD, Schizophrenia, and Bipolar Disorder. Services are delivered in-person at its Houston location and via telepsychiatry, with board-certified psychiatrists and psychiatric nurse practitioners providing both diagnostic and ongoing treatment services.

Differentiator

Problem solved

Functional benefit

Products and services

• TMS Therapy (Transcranial Magnetic Stimulation) Non-invasive neuromodulation treatment using MRI-strength magnetic pulses to stimulate underactive brain regions involved in mood regulation. FDA-cleared for major depressive disorder, anxious depression, and OCD; used to address treatment-resistant depression in adults.
• Spravato (Esketamine) Treatment FDA-approved prescription nasal spray containing esketamine used alongside an oral antidepressant for adults with treatment-resistant depression. Targets NMDA receptors and glutamate pathways for faster symptom relief.
• Medication Management Personalized medication reviews, ongoing monitoring, side-effect tracking, and prescription adjustments for children, adolescents, and adults receiving treatment for mental health disorders.
• Suboxone Treatment Medication-assisted treatment combining buprenorphine and naloxone to support individuals managing opioid dependence, reducing cravings and withdrawal symptoms under medical supervision.
• TOVA (Test of Variables of Attention) Computerized visual attention assessment used to aid in the diagnosis and treatment evaluation of ADHD, objectively measuring attention, impulse control, and response time.
• Genetic Testing Genetic analysis to determine how an individual's body may metabolize psychiatric medications, reducing trial-and-error in medication selection for mental health treatment.
• Psychiatric Evaluations Comprehensive structured clinical interviews covering mental health history, current symptoms, medical history, and personal background to establish diagnoses and inform personalized care planning.
• Chemical Dependency Treatment Treatment for substance use disorders and co-occurring mental health conditions including psychiatric evaluation, medication-assisted treatment (e.g., Suboxone), counseling coordination, and structured recovery planning.
• Eating Disorder Treatment Psychiatric evaluation, medication management, and coordinated care for conditions such as anorexia and bulimia, addressing both behavioral symptoms and co-occurring anxiety, depression, ADHD, PTSD, and OCD.
• ADHD/ADD Treatment Comprehensive psychiatric evaluations, medication management, and ongoing care for ADHD and ADD addressing focus, impulse control, executive functioning, and daily task management.
• Schizophrenia Treatment Comprehensive psychiatric evaluation, antipsychotic medication management, and ongoing monitoring of symptoms, daily functioning, sleep, and relapse warning signs for children, adolescents, and adults with schizophrenia.
• Bipolar Disorder Treatment Personalized care plans combining mood stabilizer medications and psychotherapy to manage mood swings, prevent relapse, and support long-term stability for individuals with bipolar disorder.
• Telepsychiatry Psychiatric evaluations, medication management, and follow-up care delivered via telemedicine for adults and adolescents, offering flexible access to care alongside in-person visits.

Quantifiable outcome

• Little to no wait times for appointments
• +1 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• EmpathxcoreStrategic or Co-development PartnerThrough Empathx MPP, Memorial Park Psychiatry is connected to clinical research in psychiatry and behavioral health. Dr. Matthew Brams serves as Principal Investigator for Empathx MPP. The broader Empathx network includes research experience in ADHD, depression, anxiety, bipolar disorder, OCD, PTSD, schizophrenia, postpartum depression, Alzheimer's disease, and Parkinson's disease.
• Beacon Behavioral PartnerscoreStrategic or Co-development PartnerMemorial Park Psychiatry is part of Beacon Behavioral Partners, a nationwide network of physician-led psychiatric practices that empowers growth and innovation in behavioral healthcare. The partnership aims to ensure patient care comes first without barriers.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Done (Done.): Digital ADHD-focused care provider offering psychiatric evaluation and medication management. Comparable to Memorial Park Psychiatry on ADHD testing (TOVA), medication management, and adult psychiatry focus.
• Cerebral: Subscription-based online mental health platform offering evaluation and medication management for depression, anxiety, ADHD, and related conditions. Comparable in telemedicine-driven psychiatry and medication management, though with a different price-point structure.
• Charlie Health: Intensive outpatient and virtual mental health provider for adolescents and young adults. Comparable in target population (children/adolescents with serious mental health conditions) and in the use of evidence-based, multi-disciplinary psychiatric care.

Direct peers

• Two Chairs: Outpatient mental health practice combining in-person and telehealth therapy and psychiatry services. Comparable to Memorial Park Psychiatry in multi-modality clinical care, insurance-based reimbursement, and clinician-led service model.
• Thriveworks: Multi-state outpatient mental health practice offering therapy, psychiatry, and medication management. Comparable business model to Memorial Park Psychiatry with in-person and virtual visits, insurance acceptance, and physician-led care.
• Greenbrook TMS NeuroHealth Centers: Multi-site outpatient provider specializing in Transcranial Magnetic Stimulation (TMS) therapy for treatment-resistant depression. Directly comparable to Memorial Park Psychiatry's NeuroStar TMS service line and outpatient clinic model.
• Brightside Health: Online psychiatry and therapy platform offering medication management and treatment for depression and anxiety, including treatment-resistant populations. Overlaps with Memorial Park Psychiatry on psychiatry-led outpatient care delivery and insurance coverage.
• Talkiatry: Telemedicine-first psychiatric practice employing board-certified psychiatrists for medication management across multiple U.S. states. Directly competes with Memorial Park Psychiatry in outpatient psychiatric evaluations, medication management, and insurance-based care delivery.

Broad incumbents

• Lyra Health: Employer-sponsored mental health benefit platform providing therapy and psychiatry services. Comparable in offering insurance-covered outpatient psychiatry, though distributed primarily through employer contracts rather than direct patient relationships.

Regional players

• Bay Psychiatry: Houston-area outpatient psychiatric practice offering medication management, TMS, and psychiatric evaluations. Comparable in service mix, geography, and physician-led care delivery to Memorial Park Psychiatry.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Customer concentration

• Facebookfacebook.com/186442438147260
• Instagraminstagram.com/memorialparkpsychiatry
• LinkedInlinkedin.com/company/memorial-park-psychiatry

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Memorial Park Psychiatry